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Nanoparticle (NP) surfaces have been widely investigated and engineered due to their
importance in the synthesis of particles for targeted drug delivery, vaccination, medical
imaging, as well as personal care products, and electronics.[1] For instance in drug delivery,
the ability to functionalize the surface of NPs with ligands for differential delivery of drugs
has demonstrated increased target cell uptake compared to equivalent NPs lacking the
ligands.[2] Similarly, modification of the surface of inorganic NP such as quantum dots, iron
oxide, and gold NPs, has been explored to render them biocompatible and non-toxic for
applications in therapeutics and diagnostics.[3] Common methods used to characterize
particle physicochemical properties include nuclear magnetic resonance (NMR), surface
plasmon resonance (SPR), X-ray diffraction (XRD), and dynamic light scattering (DLS),
among others.[4] However, while these techniques tend to measure the properties of a
population of particles, they tend to overlook the surface characteristics of single particles
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such as ligand distribution and charge density distribution over the particle surface, which
could greatly impact their expected interaction with cells, proteins or other particles.
Heterogeneous arrangement of ligands or functional groups on particle surfaces could result
in the formation of clusters or ‘patches’, which may bestow the particle with different
functionalities compared to those with uniformly distributed ligands. For instance, patchy
particles can self-assemble into 2D and 3D structures of different sizes and shapes, which
could be implemented for the self-assembly of devices in which instructions for assembly
emerge from the nature of the forces acting between constituents, or it could bring insights
to the thermodynamics and kinetics of molecule self-assembly at the atomic scale.[5] In the
area of drug delivery patchy NPs presenting clusters of targeted ligands, have demonstrated
to have higher efficacy than those NPs with homogenous distribution of the ligand around
the surface, which may be attributed partly to the increased avidity due to clustering.[6]
Finally, patchy NPs could be useful in the area of in vitro diagnostics where surface
heterogeneity allows for simultaneous interaction with both a substrate and a reporter
biomolecule, thus decreasing the number of components in the system.[7]
While the engineering of patchy particles has been widely investigated and several multi-
step techniques have been developed (e.g. template-assisted fabrication,[8] evaporation-
driven colloidal assembly,[9] particle lithography,[10] glancing-angle vapor deposition,[11]
nanoparticle lithography,[12] and electrified jetting),[13] single step self-assembly of patchy
particles has been less commonly observed. Indeed, surface heterogeneity of particles has
been observed mostly for nanocrystals composed of metals such as selenium, cadmium,
tellurium, zinc, and copper, among others.[14] For example, CdTe nanowires with
heterogeneous surface properties were observed when organic coatings with two different
structures and chemical properties were deposited onto the nanowire forming patches to
minimize the surface energy.[15] However, for the case of organic particles such as
polymeric or lipid-based NPs and microparticles (MPs) spontaneous formation of patches
during or after self-assembly has not been observed.
Here, we report the visualization of patches formed on NP and MP surfaces of polymer-lipid
hybrid particles exhibiting a core-shell structure. These particles contain a hydrophobic
homogeneous core composed of poly(D,L-lactide-co-glycolide) (PLGA), and a hydrophilic
shell composed of a mixture of lecithin and 1,2-distearoyl-sn-glycero-3-
phosphoethanolamine (DSPE)-N-polyethylene glycol (PEG) with different terminal-
functional groups, such as NH2, OCH3 and maleimide (MAL) that is physically adsorbed
onto the PLGA core through hydrophobic-hydrophobic interactions. In NPs, the formation
of patches emerged from the segregation of DSPE-PEG-NH2 and DSPE-PEG-OCH3, and
their visualization by TEM was accomplished by conjugating carboxylated quantum dots
(QDs) to the NH2 groups on the NP surface. Similarly patches were observed on MPs by
conjugating gold NPs to NH2 groups on the particle surface, or by the conjugation of a
fluorescent dye to the MAL groups on DSPE-PEG-MAL prior to particle self-assembly. As
proof-of-concept for taking advantage of this phenomenon for the synthesis of particles with
multiple functionalities for potential biomedical applications, we conjugated two different
bioactive proteins to NH2 and MAL groups on a MP surface followed by visualization of
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protein clusters using confocal microscopy. Finally, we demonstrated synergistic binding of
patchy particles with dual functionalization to B cells.
Our model particles are composed of a PLGA core and a shell composed of lecithin and
DSPE-PEG with terminal functional groups NH2 OCH3, and MAL referred to as NPs-NH2
NPs-OCH3 and NPs-MAL, respectively. The formation of these particles involves a single
mixing step where PLGA in an organic water-miscible solvent like acetonitrile is mixed
with an aqueous solution containing lecithin and DSPE-PEG (Figure 1A).[16] Prior to
preparing NPs with two functional groups, we first synthesized 80–100 nm NPs with a
single surface functional group, NH2 as previously reported by our group (Figure 1B).[17]
Next, NHS-activated QDs of 5 nm in size were conjugated to the NH2 groups on the particle
surface to investigate their spatial distribution throughout the surface followed by their
visualization through TEM. The resulting image shows evenly distributed QDs on the NPs-
NH2 particle surface, revealing the random localization of NH2 on the NP surface (Figure
1C). Subsequently, we investigated the arrangement of two different functional groups on
the particle surface by mixing DSPE-PEG-NH2 and DSPE-PEG-OCH3 at a 50% molar ratio
in the aqueous solution followed by the same synthesis procedure as done for previous NPs.
The presence of the NH2 groups was identified by the immobilization of QDs, while the
OCH3 groups were unmodified. TEM images show clusters of quantum dots on the particle
surface, which suggests the formation of patches formed by the clustering of DSPE-PEG-
NH2 chains (Figure 1D).
With the goal of investigating whether the formation of patches also occurred at the micron-
scale instead of being a phenomenon displayed exclusively at the nano-scale, we prepared
MPs with a similar composition through an emulsification-based method. In this method,
PLGA was dissolved in ethyl acetate and the solution was then emulsified using a
homogenizer with an aqueous solution that contained DSPE-PEG-NH2 (50%), DSPE-PEG-
MAL (50%) (molar ratio). After the organic solvent was evaporated, NH2 groups were
traced with 5-nm gold NPs followed by their visualization with TEM (Figure 2A) and SEM
(Figure 2B). The dark region in Figure 2A demonstrates the presence of gold, which
indicates the cluster formation of DSPE-PEG-NH2 chains on the particle surface. SEM
images also revealed the presence of NH2 functional groups through the visualization of
gold NPs. The patches on these MPs were much bigger than the ones observed for the NPs
presumably due to the absence of lecithin and the increased amount of DSPE-PEG relative
to PLGA.
To investigate whether the formation of patches is induced by the conjugation of gold NPs
or QDs to NH2 groups after particle formation rather than patch formation during particle
self-assembly, we conjugated SAMSA fluorescein to the MAL group in DSPE-PEG-MAL
chains before particle formation, followed by the formation of MPs composed of 50%
DSPE-PEG-NH2 and 50% DSPE-PEG-MAL through the previously described
emulsification method (Figure 2C). In addition, we added the hydrophobic dye BODIPY-X
to the PLGA organic solution to enable the visualization of the particle core by
encapsulating the dye (Figure 2D). Confocal laser scanning microscopy was used to image
both fluorescein on the particle surface and BODIPY-X in the particle core. Figure 2E
shows the resulting MPs displaying patches located in one of the spheres’ poles similarly to
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what was observed for MPs functionalized with gold NPs. These results suggest that
segregation of surface functional groups into patches during self-assembly is a more general
occurrence and not induced by conjugation of gold NPs or QDs after particle formation.
After discovering the formation of patches both on NPs and MPs, we evaluated if particles
exhibiting patches with different functionalities could be synthesized by conjugating two
biomolecules selectively onto different patches. Due to the limited resolution of the confocal
microscope, bioconjugation was only carried out for MPs. In this study, a C3d fragment and
a Hen Egg Lysozyme (HEL) were used as model biomolecules to attach on the surface of
the particles. C3d is 35 kDa protein, member of the 35 complement proteins, and is an
excellent natural adjuvant.[18] HEL is a 14 kDa model lysozyme, which is a protein that
plays an important role in bacterial infections and other diseases.[19] Both biomolecules are
of biological relevance in the synthesis of vaccines since C3d is a potent molecular adjuvant
when conjugated to a soluble antigen[18] and HEL is a non-toxic antigen often used in
animal models.[19, 20] C3d was covalently attached to the NH2 groups on the MPs surface
using the Sulfo LC-SPDP spacer, while HEL was covalently attached to the MAL groups on
the MPs via sulfide bond with thiol groups present in HEL (Figure 3A). A representative
three-dimensional confocal microscopy image demonstrated the presence of C3d (blue)
(Figure 3B) and HEL molecules (green) (Figure 3C) located on the MP surface. The
presence of both proteins on different regions of the particle surface is an indication of the
distribution of a number of MAL and NH2 functional groups away from each other (Figure
3D). Interestingly, although in the particle formulation the ratio between MAL and NH2 is
50/50, we observed greater coverage by C3d on the NP surface compared to the one
observed by HEL. This is likely due to the interaction of the thiol groups present on C3d[21]
with both the pyridinyldisulfide part of Sulfo-LC-SPDP crosslinker which was used to bind
C3d covalently to NH2 groups of the particles, and with MAL groups of the particles. HEL
which has thiol groups on its surface interacts primarily with MAL groups of the MPs.
Nevertheless, the fact that both proteins are present on the particle surface and that there are
regions in which one type of protein formed clusters, could result in the generation of higher
immune response compared to the one generated in the presence of only C3d or HEL.
Finally, as a proof of concept for the potential applications of these particles in the design of
vaccines, we investigated the binding of patchy microparticles to B cells. These particles
were functionalized with either Turkey Egg Lysozyme (an antigen and a homologous
protein of HEL) and C3d (a natural adjuvant) or both proteins. Our hypothesis was that
having both TEL and C3d on the same particle would potentially induce a higher immune
response by B cells compared to administrating TEL and C3d in separate particles.
In vitro experiments were carried out with B Cells extracted from an MD4 transgenic
mouse, which have overexpressed receptors specifically for TEL. In these experiments, we
compared the uptake of particles having clusters of C3d, TEL or both on the surface. For
detection, C3d and TEL were labeled with Alexa 647 and 488, respectively, and their
interaction with B cells was measured by FACS. Figure 4a shows the fluorescent
background of cells exposed to particles with no proteins on the surface. When B cells were
incubated with particles containing C3d only (MP+C3d), an increase in C3d signal was
observed for a low fraction of the cells (Figure 4b), presumably via the specific binding of
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C3d to CR2 receptor present in the surface of B cells. When cells were incubated with
particles containing TEL only (MP+TEL), an increase in TEL signal was observed for most
of the cells (Figure 4d) through the specific binding of TEL lysozymes to B cell receptors
present in B cells. However, when MPs functionalized with clusters of both C3d and TEL
(MP+C3d+TEL), a similar increase in signal was observed for TEL compared to MP+TEL,
but now this time the signal for C3d was increased for a much larger fraction of the cells
compared to MP+C3d (i.e. 6-fold increase; Figure 4c). The synergistic effect elicited by MP
+C3d+TEL in B cells could potentially be useful to amplify the immune response since now
higher titers of adjuvant C3d would be present in the cells. Further experiments will be
needed to show the immune response induced by these particles, and therefore their use as a
new type of vaccine.
These results demonstrate through different methods, the spontaneous formation of
heterogeneous patches on NP and MP surfaces by coating them with relatively long lipid-
polymeric chains differing only by their terminal group. This phenomenon was somewhat
unexpected in light of the fact that NH2 groups, having a positive charge at neutral pH,
would tend to repel each other due to charge repulsion rather than forming clusters. A
similar experimental observation was reported before[22, 23] where it was found that charged
and uncharged phospholipids segregated when blended and deposited on negatively charged
silica beads.[22] In this case, it was concluded that the driving force for this phenomenon was
mainly due to the electrostatic potential arising from the silica beads. The phase segregation
phenomenon has also been observed in binary self-assembly monolayers (SAM) of n-
alkanethiols on Au{111}[24, 25] surfactant-coated nanoparticles and surfactant-coated flat
substrates.[26] The mechanism involved in the formation of phase segregated domains in
each of these cases is different. For example, in SAM phase segregation seems to be driven
by factors such as the surface diffusion of the SAM onto the substrate (e.g. gold), thiol
exchange, coalescence and motion of alkanethiolates.[24, 25] In nanoparticles coated by two
different surfactants, the curvature of the particles plays a key role in the formation of stripe-
like domains and randomly distributed patches over the nanoparticle surface.[26] The higher
the curvature of the substrate the most likely to observe wormlike stripes and randomly
distributed patches over the surface.[26] In our study, the mechanism involved in the
segregation of the lipid-pegylated functional groups is likely to be different, since the
formation of patches seems to take place during the particle self-assembly rather than post-
particle assembly. Also, other parameters such as the molecular weight of the DSPE-PEG-
end functional group might have an influence in the formation of phase segregated domains.
For example, high molecular weights (e.g. 10 000, 20 000 kDa) could cause the
entanglement of PEG which might decrease its mobility, and thus impair segregation. In
addition, other thermodynamics factors such as the minimization of energy might be
involved in this phenomenon as previously observed in lipid segregation.[27] It is known that
lipid layers tend to have lateral mobility in cell membranes and unilamelar vessels forming
lipid ‘rafts’ that selectively interact with specific molecules.[28] Considering that DSPE
forms a lipid monolayer on the PLGA core, it might be possible that lipids adsorbed
rearrange themselves to form patches with the aim of minimizing surface energy. Further
studies are needed to validate the abovementioned hypotheses and gain thorough
understanding of the phase space where self-assembly occurs. While more effort should be
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devoted to understand and control the number and size of patches formed on a particle
surface, this is a proof of concept of the creation of a new class of particles with multiple
functionalities on a heterogeneous surface, and yet preserving a homogenous core for other
purposes (e.g. encapsulation of agents). Equally important, these results present important
implications for the future design of NPs or MPs that contain different groups on the
surface. For instance, in drug delivery there are previous studies, including some from our
own group, where polymers or lipids with different functional groups or ligands are mixed
to obtain particles with different charge[17a] or ligand density.[29] While it has been
previously assumed that ligands or charged groups are homogenously distributed throughout
the particle surface, it might well be that ligand clusters or patches self-assembled on the
particle surface potentially affect the behavior of the NPs. Specifically, in the case of
particles that are coated with a fraction of lipids or polymers terminated with NH2 positively
charged patches could have been formed resulting in spots of high charge density that could
increase the cytotoxicity of the particle and/or the interaction with blood proteins. In
addition, in the case of targeted NPs formed by mixing ligand-conjugated polymers with
unmodified ones,[29, 30] clusters of ligands could be formed unexpectedly increasing or
decreasing the uptake by the target cell.
Finally, further understanding of this phenomenon could result in the facile formation and
engineering of patchy NPs with multiple functionalities that do not require multi-step and
relatively elaborate methodologies. The fact that these particles are synthesized with
clinically validated biomaterials such as PLGA, PEG and lipids, could enable the
engineering and rapid clinical translation of multifunctional patchy NPs and MPs that can
encapsulate a specific agent in their core and have multiple functionalities on their surface.
A goal of future studies will focus on understanding what factors determine the size and
number of patches on the particle surface and how they can be controlled for a specific
application. In summary, we believe these findings are both important and exciting and
should be taken into account as one of the particle design factors.
In conclusion, we report and demonstrate the spontaneous formation of patches on the
surface of core-shell nanoparticles and microparticles. These patches were formed by the
segregation of DSPE-PEG chains differing in functional end-groups that can be modified to
have novel functionalities such as different biomolecules selectively presented on distinct
patches on the surface. Patch formation was observed by TEM for NPs and TEM, SEM, and
confocal microscopy for MPs. In vitro experiments show a synergistic effect created by the
presence of two different proteins on the particle’s surface. Finally, these findings could
have important implications for the future design of self-assembled NPs and MPs for drug
delivery carriers, and other biomedical applications.
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Figure 1.
Formation of patchy NPs via a modified self-assembly process. A) Schematic diagram of the
formation of NPs via self-assembly of DSPE-PEG terminated with NH2 and OCH3, lecithin,
and the hydrophobic PLGA polymer. The distribution of the NH2 functional groups was
visualized with TEM through its conjugation with carboxylated quantum dots. B) NPs
synthesized only with DSPE-PEG-NH2. C) NPs-NH2 traced with carboxylated quantum
dots revealed the random distribution of the amino groups on NP surface. D) NPs
synthesized with DSPE-PEG-NH2 (50%) and DSPE-PEG-OCH3 (50%) and traced with
QDs revealed the patchy character of these particles.
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Figure 2.
Characterization of patchy MPs with TEM, SEM and Confocal Laser Scanning Microscopy
(CLSM). A) Unstained TEM image of patchy MPs synthesized with DSPE-PEG-NH2 (50%)
and DSPE-PEG-MAL (50%), where the gold NPs were conjugated to NH2 groups on the
MP surface (Dark region). B) SEM image of the above mentioned particles. C) CLSM
image of patchy MPs synthesized via the emulsion method. MPs were synthesized with
DSPE-PEG having two different functional groups (DSPE-PEG-NH2 (50%)/DSPE-PEG-
MAL(50%)). DSPE-PEG-MAL patch was labeled with SAMSA fluorescein (green), while
DSPE-PEG-NH2 patch was not labeled. D) Bodipy-X was encapsulated in the core for
particle visualization (red). E) The overlay of the individual fluorescence channels shows the
formation of patches on the MP surface.
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Figure 3.
Schematic illustration of the formation of patchy MPs and their functionalization with C3d
and HEL. A) 3D confocal microscopy of Patchy MPs. These particles were synthesized with
DSPE-PEG-NH2 (50%) and DSPE-PEG-MAL (50%), and were subsequently functionalized
with C3d and HEL, respectively. CLSM images correspond to labeled C3d with Alexa 647
covalently attached to the NH2 functional groups of MPs via the Sulfo-LC-spacer (B),
labeled HEL with Alexa 488 covalently attached to the MAL groups via sulfide bond with
thiol groups present in HEL (C). Overlay of C3d and HEL shows the presence of a patch
formed by HEL biomolecules (D).
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Figure 4.
MD4 mouse B cells targeted by microparticles functionalized with labeled C3d, TEL and
C3d+TEL. A) MP (fluorescent background of B cells exposed to particles with no
fluorescent labeled proteins on the surface); B) MP+C3d (fluorescent signal of B cells
exposed to particles containing only labeled C3d); C) MP+C3d+TEL (fluorescent signal of
B cells exposed to particles containing both labeled C3d and TEL); D) MP+TEL
(fluorescent signal of B cells exposed to particles containing only labeled TEL). The binding
of MP+C3d to B cells is relatively low (8%), whereas the binding of MP+TEL to B cells is
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relatively high (91%), because of the specific binding of TEL lysozymes to B cell receptors
in B cells. For particles with both C3d and TEL on their surface (MP+C3d+TEL), not only a
similar percentage of B targeting by TEL occurs, but also the signal of C3d in B cells is
increased by approximately 6-fold (49%).
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